TipRanks
Advertisement
Advertisement

RNA Stock Latest News

Atrium Therapeutics earns $15M milestone payment from Bristol Myers
The FlyAtrium Therapeutics earns $15M milestone payment from Bristol Myers
1M ago
BMY
RNA
Atrium Therapeutics reports Q2 EPS ($1.18) vs (75c) last year
PremiumThe Fly
Atrium Therapeutics reports Q2 EPS ($1.18) vs (75c) last year
1M ago
RNA
Zillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Zillow downgraded, Global Payments upgraded: Wall Street’s top analyst calls
1M ago
Z
ZG
Atrium Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Atrium Therapeutics initiated with a Buy at H.C. Wainwright
1M ago
RNA
Atrium Therapeutics announces FDA clearance of ATR 1072 IND application
PremiumThe Fly
Atrium Therapeutics announces FDA clearance of ATR 1072 IND application
2M ago
RNA
Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyAtrium Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
RNA
Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
RNA
Leerink starts ‘interesting preclinical-stage opportunity’ Atrium at Outperform
Premium
The Fly
Leerink starts ‘interesting preclinical-stage opportunity’ Atrium at Outperform
4M ago
RNA
Atrium Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Atrium Therapeutics initiated with an Outperform at Leerink
4M ago
RNA
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
4M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
4M ago
DYN
RNA
Atrium Therapeutics earns $15M development milestone payment from Bristol Myers
PremiumThe Fly
Atrium Therapeutics earns $15M development milestone payment from Bristol Myers
5M ago
BMY
RNA
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe FlyHemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
5M ago
DYN
RNA
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
6M ago
MUB
NFE
Atrium Therapeutics initiated with an Overweight at Wells Fargo
Premium
The Fly
Atrium Therapeutics initiated with an Overweight at Wells Fargo
6M ago
RNA
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
6M ago
AZN
BMY
RNA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
RNA Earnings this Week: How Will it Perform?
7M ago
RNA
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories!
7M ago
DIA
RNA
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
PremiumCompany Announcements
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
7M ago
8K
RNA
Atrium Therapeutics launches as newly independent, publicly traded company
PremiumThe FlyAtrium Therapeutics launches as newly independent, publicly traded company
7M ago
NVS
RNA
Novartis completes acquisition of Avidity Biosciences
Premium
The Fly
Novartis completes acquisition of Avidity Biosciences
7M ago
NVS
RNA
Why Is Avidity Biosciences Stock (RNA) Down Today?
Premium
Market News
Why Is Avidity Biosciences Stock (RNA) Down Today?
7M ago
NVS
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >